NP2GO
  • Weight Loss
    • Online Visits
    • In-Person Visits
    • Understanding GLP1
    • Semaglutide
    • Tirzepatide
    • Weight Loss Shot Injection Guide
  • Hormone Therapy
    • HRT for Menopause
    • TRT
  • Peptides
    • Understanding Peptide Therapy
    • NAD+
  • Urgent Care
  • IV Hydration
  • Aesthetics
  • Supplements
  • About
    • FAQs
    • Reviews
    • Service Areas
    • Gift Cards
  • Blog
  • Contact
  • Weight Loss
    • Online Visits
    • In-Person Visits
    • Understanding GLP1
    • Semaglutide
    • Tirzepatide
    • Weight Loss Shot Injection Guide
  • Hormone Therapy
    • HRT for Menopause
    • TRT
  • Peptides
    • Understanding Peptide Therapy
    • NAD+
  • Aesthetics
  • Hydration
  • Urgent Care
  • Supplements
  • About
    • FAQs
    • Reviews
    • Service Areas
    • Gift Cards
  • Blog
  • Contact
Wegovy Pills vs. Foundayo: Which Daily Weight Loss Pill is Right for You?

Wegovy Pills vs. Foundayo: Which Daily Weight Loss Pill is Right for You?

by Lucy Nongari Kariuki | Apr 30, 2026 | Weight Loss Information Blogs

Wegovy pills (oral semaglutide) and Foundayo (orforglipron) are new, non-needle daily GLP-1 tablets for weight loss, both available as of April 2026. Wegovy pills have shown slightly higher weight loss in indirect studies, while Foundayo offers convenience by not...
Foundayo (Orforglipron): The New Once-Daily Oral GLP-1 Pill for Weight Loss

Foundayo (Orforglipron): The New Once-Daily Oral GLP-1 Pill for Weight Loss

by Lucy Nongari Kariuki | Apr 17, 2026 | Weight Loss Information Blogs

Foundayo (orforglipron) is a once‑daily glucagon‑like peptide‑1 (GLP‑1) receptor agonist. It’s approved for weight loss in people with obesity or overweight and have weight-related health conditions like high blood pressure, high cholesterol, type 2 diabetes,...
Best Alcohol Choices (If You Drink) While on GLP-1 Medications

Best Alcohol Choices (If You Drink) While on GLP-1 Medications

by Lucy Nongari Kariuki | Apr 10, 2026 | Weight Loss Information Blogs

You started on GLP-1s; your appetite is reduced, you feel full faster, and you no longer experience food noise. But you wonder, “Can I still enjoy alcohol on semaglutide or tirzepatide, and if so, what are the best choices?”   The short answer is yes. In most cases,...
Higher Dose of Wegovy: What the New FDA Approval Means for Weight Loss

Higher Dose of Wegovy: What the New FDA Approval Means for Weight Loss

by Lucy Nongari Kariuki | Apr 7, 2026 | Weight Loss Information Blogs, Weight loss OKC Blogs

If you’ve been faithfully following your 2.4 mg Wegovy regimen, eating a calorie-reduced diet, and exercising more and still plateaued, the new 7.2 mg dose could help you break through.   Wegovy, a brand name for the medicine semaglutide, is a once-weekly GLP-1...
TRT vs. Steroids: What’s the Difference?

TRT vs. Steroids: What’s the Difference?

by Lucy Nongari Kariuki | Mar 31, 2026 | Hormone Replacement Therapy Blogs

If you’re a man in your 30s, 40s, or beyond feeling constantly tired, gaining stubborn belly fat, losing motivation in the gym, or struggling with low libido or erections, you’ve probably heard of testosterone replacement therapy (TRT) and steroids. You’re confused...
« Older Entries
Next Entries »

Recent Posts

  • How Long Does It Take for Zepbound (Tirzepatide) to Work?
  • Can Menopausal Women Benefit From Weight Loss Drugs Like Wegovy and Zepbound?
  • Switching From Wegovy to Zepbound: The Ultimate Guide
  • Mobile IV Infusion Therapy in Tulsa, Oklahoma
  • Medical Weight Loss Clinic in Oklahoma City

Recent Comments

No comments to show.
NP2GO
Join Our Email List


(405) 696-7003



admin@thenp2go.com



800 W 18th St. Ste. 220
Edmond, Oklahoma 73013



By Appointment Only

Verify Approval for thenp2go.com
Verify Approval for thenp2go.com

Support

FAQs

Reviews

Pricing

Contact

About

Blog

Careers

Media Inquiry

Privacy & Terms

Weight Loss

Virtual Visits

In-Person Visits

Our Service Areas

Copyright © 2026 NP2GO All Rights Reserved. Website designed by myheartcreative.
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow